A detailed history of Capital Management Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Management Associates holds 1,600 shares of LLY stock, worth $1.31 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
1,600
Holding current value
$1.31 Million
% of portfolio
1.52%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $947,520 - $1.27 Million
1,600 New
1,600 $1.24 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $401,937 - $468,337
1,250 Added 50.0%
3,750 $1.37 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $627,142 - $736,357
2,250 Added 900.0%
2,500 $810,000
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $58,672 - $72,915
250 New
250 $72,000
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $731,214 - $853,512
-6,600 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $698,940 - $783,024
6,600 New
6,600 $764,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $780B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Capital Management Associates Portfolio

Follow Capital Management Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Associates , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Associates with notifications on news.